- Home
- DDI vs REPL Comparison
DDI vs REPL Comparison
Compare DDI & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDI
- REPL
- Stock Information
- Founded
- DDI 2008
- REPL 2015
- Country
- DDI South Korea
- REPL United States
- Employees
- DDI N/A
- REPL N/A
- Industry
- DDI EDP Services
- REPL Biotechnology: Pharmaceutical Preparations
- Sector
- DDI Technology
- REPL Health Care
- Exchange
- DDI Nasdaq
- REPL Nasdaq
- Market Cap
- DDI 738.3M
- REPL 816.4M
- IPO Year
- DDI 2021
- REPL 2018
- Fundamental
- Price
- DDI $15.52
- REPL $10.80
- Analyst Decision
- DDI Strong Buy
- REPL Strong Buy
- Analyst Count
- DDI 3
- REPL 4
- Target Price
- DDI $22.67
- REPL $17.00
- AVG Volume (30 Days)
- DDI 71.1K
- REPL 432.6K
- Earning Date
- DDI 11-11-2024
- REPL 11-12-2024
- Dividend Yield
- DDI N/A
- REPL N/A
- EPS Growth
- DDI N/A
- REPL N/A
- EPS
- DDI 2.30
- REPL N/A
- Revenue
- DDI $342,458,000.00
- REPL N/A
- Revenue This Year
- DDI N/A
- REPL N/A
- Revenue Next Year
- DDI $1.98
- REPL $469.74
- P/E Ratio
- DDI $6.75
- REPL N/A
- Revenue Growth
- DDI 13.42
- REPL N/A
- 52 Week Low
- DDI $7.16
- REPL $4.92
- 52 Week High
- DDI $18.21
- REPL $12.97
- Technical
- Relative Strength Index (RSI)
- DDI 54.12
- REPL 38.50
- Support Level
- DDI $15.40
- REPL $11.45
- Resistance Level
- DDI $18.21
- REPL $12.73
- Average True Range (ATR)
- DDI 1.10
- REPL 0.69
- MACD
- DDI 0.08
- REPL -0.16
- Stochastic Oscillator
- DDI 43.21
- REPL 8.82
About DDI DoubleDown Interactive Co. Ltd. American Depository Shares
DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. Its market opportunity includes casual gaming globally, which includes slots, puzzles, cards, match three, and other similar games. Within the social casino segment of casual gaming, which includes free-to-play online slots, poker, table games, and bingo. Other games developed by the company are DoubleDown Fort, DoubleDown Classic, and Ellen's Road to Riches. The company has a presence in the international market, and it derives a majority of its revenue from the United States of America.
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.